Cargando…

In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017

Eravacycline is a novel, fully synthetic fluorocycline antibiotic developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens. Here, we evaluated the in vitro activities of eravacycline and comparator antimicrobial agents against a global collecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morrissey, Ian, Olesky, Melanie, Hawser, Stephen, Lob, Sibylle H., Karlowsky, James A., Corey, G. Ralph, Bassetti, Matteo, Fyfe, Corey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Epidemiology and Surveillance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038303/ https://www.ncbi.nlm.nih.gov/pubmed/31843999 http://dx.doi.org/10.1128/AAC.01699-19

Ejemplares similares

In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017
por: Morrissey, Ian, et al.
Publicado: (2020)

In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from U.S. and European Hospitals during 2014–2015
por: Morrissey, Ian, et al.
Publicado: (2019)

915. Global 2018 Surveillance of Eravacycline Against Gram-positive Pathogens, Including Resistant Isolates
por: Morgan, Steven, et al.
Publicado: (2020)

Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017
por: Krone, Manuel, et al.
Publicado: (2019)

1613. Global 2018 Surveillance of Eravacycline Against Gram-negative Pathogens, Including Multi-drug Resistant Isolates
por: Lijfrock, Virgil, et al.
Publicado: (2020)

2133. Surveillance of Eravacycline Against Gram-positive Clinical Pathogens, Including Resistant Isolates, Collected Worldwide From Multiple Infection Sites During 2021
por: Hawser, Stephen, et al.
Publicado: (2023)

Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020)
por: Arends, S. J. Ryan, et al.
Publicado: (2023)

Nationwide Surveillance and Molecular Characterization of Critically Drug-Resistant Gram-Negative Bacteria: Results of the Research University Network Thailand Study
por: Yungyuen, Thitiya, et al.
Publicado: (2021)

Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010–2019)
por: Carvalhaes, Cecilia G., et al.
Publicado: (2022)

In Vitro Activity of Cefiderocol Against Meropenem-Nonsusceptible Gram-Negative Bacilli with Defined β-Lactamase Carriage: SIDERO-WT Surveillance Studies, 2014–2019
por: Wise, Mark G., et al.
Publicado: (2023)

In Vitro Activity of Eravacycline against Carbapenemase-Producing Gram-Negative Bacilli Clinical Isolates in Central Poland
por: Brauncajs, Małgorzata, et al.
Publicado: (2023)

Q fever in Bulgaria: Laboratory and epidemiological findings on human cases and outbreaks, 2011 to 2017
por: Genova-Kalou, Petia, et al.
Publicado: (2019)

New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017
por: Wirden, Marc, et al.
Publicado: (2019)

Incidence of Macrosomia in Rural Areas — Henan Province, China, 2013–2017
por: Lin, Shiqi, et al.
Publicado: (2021)

Tuberculosis in Canada: 2017
por: LaFreniere, M, et al.
Publicado: (2019)

Is clinical primary care surveillance for tularaemia a useful addition to laboratory surveillance? An analysis of notification data for Finland, 2013 to 2019
por: Hammer, Charlotte C, et al.
Publicado: (2022)

In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories
por: Pfaller, Michael A., et al.
Publicado: (2018)

Antimicrobial use trends, Israel, 2012 to 2017
por: Dickstein, Yaakov, et al.
Publicado: (2019)

Pharmacokinetics (PK) of Eravacycline in Subjects with Renal or Hepatic Impairment Compared with Healthy Subjects
por: Horn, Patrick, et al.
Publicado: (2017)

Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
por: Ramette, Alban, et al.
Publicado: (2021)

Trends and regional variations of gonococcal antimicrobial resistance in the Netherlands, 2013 to 2019
por: Visser, Maartje, et al.
Publicado: (2022)

West Nile virus illness in Ontario, Canada: 2017
por: Wijayasri, S, et al.
Publicado: (2019)

Epidemiology of Clostridioides difficile infections, France, 2010 to 2017
por: Colomb-Cotinat, Mélanie, et al.
Publicado: (2019)

The changing epidemiology of diphtheria in the United Kingdom, 2009 to 2017
por: Gower, Charlotte M, et al.
Publicado: (2020)

Burden of varicella complications in secondary care, England, 2004 to 2017
por: Bernal, James Lopez, et al.
Publicado: (2019)

Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017
por: Nuttens, Charles, et al.
Publicado: (2022)

Investigation of airport sewage to detect importation of poliovirus, Poland, 2017 to 2020
por: Krzysztoszek, Arleta, et al.
Publicado: (2022)

Legionnaires’ disease in the EU/EEA*: increasing trend from 2017 to 2019
por: Samuelsson, Jonas, et al.
Publicado: (2023)

644. Comparative Evaluation of ETEST® ERV bioMérieux with the CLSI Broth Microdilution Method for Eravacycline MIC Determination
por: Sauvonnet, Veronique, et al.
Publicado: (2019)

Lessons from intensified surveillance of viral hepatitis A, Israel, 2017 and 2018
por: Gozlan, Yael, et al.
Publicado: (2021)

Epidemiology and genotype 3 subtype dynamics of hepatitis E virus in Belgium, 2010 to 2017
por: Suin, Vanessa, et al.
Publicado: (2019)

Pitfalls of rubella serology while on the brink of elimination: evaluation of national data, Belgium, 2017
por: Colman, Sofie, et al.
Publicado: (2021)

Emergence and persistent spread of carbapenemase-producing Klebsiella pneumoniae high-risk clones in Greek hospitals, 2013 to 2022
por: Tryfinopoulou, Kyriaki, et al.
Publicado: (2023)

709. Activity of Key β-Lactam Agents Against Gram-Negative Bacilli From ICU Patients with Lower Respiratory Tract Infections, SMART United States 2015–2017
por: Lob, Sibylle, et al.
Publicado: (2018)

Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015
por: Karlowsky, James A., et al.
Publicado: (2017)

Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening
por: Harvala, Heli, et al.
Publicado: (2019)

Group A rotavirus surveillance before vaccine introduction in Italy, September 2014 to August 2017
por: Ianiro, Giovanni, et al.
Publicado: (2019)

Screening for Candida auris in patients admitted to eight intensive care units in England, 2017 to 2018
por: Sharp, Ashley, et al.
Publicado: (2021)

Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020
por: Debin, Marion, et al.
Publicado: (2022)

Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020
por: Matczak, Soraya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ce72qa4bnffgkpd7ksskbum6h1